AM Technology joins EU funded flow chemistry project

Published: 21-Sep-2009
Manufacturing Sustainability Research & Development

AM Technology, a UK developer of chemical reactors and reactor control systems, has joined an EU-funded project that seeks to develop flow processes for the industrial synthesis of pharmaceutical compounds.


AM Technology, a UK developer of chemical reactors and reactor control systems, has joined an EU-funded project that seeks to develop flow processes for the industrial synthesis of pharmaceutical compounds.

AM Technology, based in Runcorn, Cheshire, says greater use of flow chemistry within the industry will bring substantial benefits in terms of reduced manufacturing costs, lower carbon footprints and less pollution. However, developing flow chemistry techniques for industrial pharmaceutical processes faces a variety of technical and regulatory hurdles and the Pharmagen project will use a multi disciplinary approach to tackle them.

The two-year Pharmagen project is being coordinated by Serichim of Italy and has other five partners. It has funding from the EU Commission DG Research within the VII Framework Programme for Research and Development.

AM Technology says its patented Coflore ACR (Agitated Cell Reactor) is the first modular multi stage CSTR and represents a breakthrough in flow reactor design. It features dynamic mixers combined with multiple reaction stages and, the company says, offers outstanding mixing, plug flow and versatility.

  • Companies:
  • AM Technology
See more

You may also like

Manufacturing

Improved reaction vessel switching in flow chemistry

Read more
"For users to be able to swap reaction vessels quickly and easily is a significant benefit, hence deciding to integrate Asynt ReactoMate ATOM into our Coflore peripheral equipment solutions"

Trending Articles

  1. You need to be a subscriber to read this article.
    Click here to find out more.
    How CDMOs can set a new gold standard when it comes to going green Sustainability is more than a feel-good initiative or a choice; it’s a strategic imperative. Not missing a beat, pharma companies have been making a concerted effort towards positive change, reports Tim Lowery, President of JSR Life Sciences and CEO, KBI Biopharma
  2. ACG expands global footprint with new capsule manufacturing facility in Thailand New capsule manufacturing facility in Rayong, Thailand, is strategically positioned to serve key Asian markets
  3. Get ahead in the pharmaceutical industry with a Manufacturing Chemist subscription With a Manufacturing Chemist subscription you receive exclusive access to the latest news, technical insights, regulatory updates, and market intelligence
  4. Thermo Fisher Scientific reveals MagMax Sequential DNA/RNA Kit to advance blood cancer research The kit combines DNA and RNA isolation chemistries into a single kit, simplifying sample extraction for a broad range of downstream molecular applications

Upcoming event

EMPQ Essentials and Real-World Strategies for Successful Cleanroom Qualifications

16 January 2025 | Virtual See all

You may also like

Manufacturing

Improved reaction vessel switching in flow chemistry

"For users to be able to swap reaction vessels quickly and easily is a significant benefit, hence deciding to integrate Asynt ReactoMate ATOM into our Coflore peripheral equipment solutions"
Manufacturing

AM Technology secures £4.1m investment

Development of new chemical reactor will have a significant impact on major UK supply chains
You need to be a subscriber to read this article.
Click here to find out more.
Ingredients

Let enzymes do the work

The use of enzyme catalysts has had a real impact on the synthesis of pharmaceutical ingredients, making it possible to improve some syntheses dramatically and even make some molecules that would otherwise be either impossible or impractical to synthesise. The use of flow reactors in biocatalysis faces challenges arising from the heterogeneous slurry nature of the reaction mixture and problems with gas and liquid handling. But research is being carried out into continuous manufacturing methods for biocatalytic reactions.
Manufacturing

Biochemist Project to develop flow process techniques for biomanufacturing

Three UK technology companies, C‐Tech Innovation, Ingenza and AM Technology are collaborating on a
Manufacturing

New flow reactor tackles scale up problems

<p>AM Technology, based in Runcorn, Cheshire, has developed a new flow reactor which it says is flexible and capable of handling problem fluids at low throughputs.</p>
Manufacturing

Ashe Morris in collaboration to co-develop glass-lined Coflux reactors

<p>Two process manufacturing companies based in the UK and Germany have teamed up to develop batch reactors with improved performance.</p><p>Ashe Morris, a specialist in the development of process equipment for the chemical and pharmaceutical industries based in Runcorn, UK has signed a collaboration agreement with Robbins & Myers Process Solutions Group (Pfaudler) for the development Coflux glass lined batch reactors.</p><p>The product uses a variable geometry heating/cooling jacket, which offers faster and more stable temperature control, the ability to set the jacket height to suit the level in the vessel and improved energy efficiency. It also provides very sensitive process heat data - serving as a robust and versatile Process Analytical Technology (PAT) tool. Batch reactor users can also improve the economics of batch process such as chemical reactions and crystallisation through real time analytical data. </p><p>As part of the collaboration, Ashe Morris and Pfaudler, a sp
Manufacturing

Ashe Morris enters into collaborative development with Pfaudler

<p>Engineering design and technology licensing company Ashe Morris has entered into a collaborative development agreement with Pfaudler, a unit of Robbins & Myers, to develop designs for industrial scale glass-lined reactors that incorporate Ashe Morris&quot; Coflux technology. </p>
Subscribe now